Capricor Therapeutics (NASDAQ:CAPR) Price Target Raised to $30.00 at Cantor Fitzgerald
Capricor Therapeutics (NASDAQ:CAPR – Free Report) had its price target raised by Cantor Fitzgerald from $25.00 to $30.00 in a research report released on Thursday morning,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Other equities research analysts have also recently issued reports about the stock. HC Wainwright reiterated a “buy” […]
More Stories
Insider Selling: Live Oak Bancshares, Inc. (NASDAQ:LOB) CAO Sells 12,588 Shares of Stock
Live Oak Bancshares, Inc. (NASDAQ:LOB – Get Free Report) CAO John W. Sutherland sold 12,588 shares of the company’s stock...
MoneyLion Inc. (NYSE:ML) CEO Sells $1,612,854.63 in Stock
MoneyLion Inc. (NYSE:ML – Get Free Report) CEO Diwakar Choubey sold 20,133 shares of the firm’s stock in a transaction...
Phong Le Sells 1,252 Shares of MicroStrategy Incorporated (NASDAQ:MSTR) Stock
MicroStrategy Incorporated (NASDAQ:MSTR – Get Free Report) CEO Phong Le sold 1,252 shares of the stock in a transaction dated...
Incitec Pivot Limited (OTCMKTS:INCZY) to Issue Dividend of $0.04
Incitec Pivot Limited (OTCMKTS:INCZY – Get Free Report) announced a dividend on Thursday, November 14th,NASDAQ Dividends reports. Investors of record...
National Bankshares, Inc. (NASDAQ:NKSH) Plans Dividend of $0.78
National Bankshares, Inc. (NASDAQ:NKSH – Get Free Report) announced a dividend on Wednesday, November 13th,NASDAQ Dividends reports. Stockholders of record...
Secom Co., Ltd. (OTCMKTS:SOMLY) Sees Large Increase in Short Interest
Secom Co., Ltd. (OTCMKTS:SOMLY – Get Free Report) saw a large growth in short interest during the month of October....